Wang DD, Cheng M, Chen CY. Intervention control of aerobic exercise in maintaining quality of life and pulmonary hypertension in hemodialysis patients. World J Clin Cases 2024; 12(20): 4217-4229 [PMID: 39015922 DOI: 10.12998/wjcc.v12.i20.4217]
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jul 16, 2024; 12(20): 4217-4229 Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4217
Table 1 General information for groups C and I, n (%)
Characteristic
Group I (n = 36)
Group C (n = 37)
P value
Gender
-
-
0.859
Male
10 (27.78)
11 (29.73)
-
Female
26 (72.22)
26 (70.27)
-
Age (yr)
48.76 ± 9.05
47.84 ± 9.02
0.608
Work situation
-
-
0.675
Be on the job
3 (8.33)
2 (5.41)
-
Depart
4 (11.11)
2 (5.41)
-
Retire
6 (16.67)
5 (13.51)
-
Farmer
21 (58.33)
24 (64.86)
-
Other
2 (5.56)
4 (10.81)
-
Per capita monthly income of households
-
-
0.874
< 1000
15 (41.67)
18 (48.65)
-
1001-2000
8 (22.22)
10 (27.03)
-
2001-3000
8 (22.22)
3 (8.11)
-
> 3000
5 (5.56)
6 (16.22)
-
Primary etiology
-
-
0.963
Nepahritis
21 (56.76)
19 (51.35)
-
Diabetes
1 (2.70)
2 (5.41)
-
Hypertensive nepahropathy
8 (21.62)
9 (24.32)
-
Other
6 (16.22)
9 (24.32)
-
Dialysis time (yr)
-
-
0.481
< 2
11 (30.56)
14 (37.84)
-
2-5
17 (47.22)
13 (35.14)
-
> 5
8 (22.22)
10 (27.03)
-
Dialysis frequency
-
-
0.624
Twice a week
16 (44.44)
14 (37.84)
-
3 times a week
10 (27.78)
9 (24.32)
-
5 times per 2 weeks
8 (22.22)
13 (35.14)
-
Other
2 (5.56)
1 (2.70)
-
Table 2 Pahysiological indicators of patients in groups C and I
Project
Group
Before treatment
After treatment
P value
Systolic pressure
Group I
155.21 ± 10.45
147.95 ± 10.10
0.004
Group C
158.91 ± 11.89
152.56 ± 12.81
0.030
t
-1.423
-3.545
-
P value
0.160
0.001
-
Diastolic pressure
Group I
86.30 ± 13.15
80.83 ± 8.33
0.039
Group C
86.78 ± 13.09
85.39 ± 10.88
0.621
t
-0.175
-1.953
-
P value
0.864
0.065
-
Myodynamia
Group I
24.17 ± 6.53
28.41 ± 7.51
0.013
Group C
24.68 ± 9.19
25.50 ± 7.80
0.680
t
-0.281
1.623
-
P value
0.780
0.033
-
Vital capacity
Group I
1801.01 ± 568.86
2341.83 ± 569.82
< 0.001
Group C
1795.01 ± 603.18
1907.20 ± 574.15
0.405
t
0.045
4.210
-
P value
0.967
0.000
-
Table 3 Positive emotional scores in groups C and I
Project
Group
Before treatment
After treatment
P value
Interested
Group I
3.00 (2.00, 3.00)
3.00 (2.00, 4.00)
0.077
Group C
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
0.986
Z
-0.828
-2.972
P value
0.407
0.003
Energetic
Group I
3.00 (2.00, 3.00)
3.00 (3.00, 4.00)
0.003
Group C
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
0.633
Z
-1.160
-4.868
P value
0.246
0.000
Determined
Group I
3.00 (2.25, 4.00)
4.00 (3.00, 4.00)
0.028
Group C
3.00 (2.00, 4.00)
3.00 (2.00, 4.00)
0.930
Z
-0.174
-2.206
P value
0.862
0.027
Highly alert
Group I
3.00 (2.00, 3.00)
3.00 (3.00, 3.75)
0.019
Group C
2.00 (2.00, 3.00)
3.00 (2.00, 3.00)
0.718
Z
-0.251
-1.961
P value
0.802
0.050
Proud
Group I
2.00 (1.00, 3.00)
3.00 (2.00, 4.00)
0.003
Group C
2.00 (1.00, 3.00)
2.00 (1.00, 2.50)
0.999
Z
-0.442
-3.614
P value
0.659
< 0.001
Focused
Group I
3.00 (2.00, 3.00)
3.00 (3.00, 3.00)
0.300
Group C
3.00 (2.00, 3.00)
3.00 (2.00, 3.00)
0.987
Z
-0.322
-1.090
P value
0.747
0.276
Encouraged
Group I
3.00 (2.00, 3.00)
2.00 (2.00, 3.00)
0.031
Group C
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
0.610
Z
-1.080
-3.037
P value
0.280
0.002
Passionate
Group I
3.00 (3.00, 4.00)
4.00 (3.00, 4.00)
0.009
Group C
3.00 (2.00, 4.00)
3.00 (2.00, 4.00)
0.926
Z
-1.532
-3.825
P value
0.125
< 0.001
Highly energetic
Group I
3.00 (2.00, 3.00)
3.00 (3.00, 4.00)
0.026
Group C
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
0.867
Z
-1.141
-3.699
P value
0.254
< 0.001
Energetic
Group I
3.00 (2.00, 3.00)
3.00 (3.00, 4.00)
0.004
Group C
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
0.831
Z
-0.606
-3.817
P value
0.544
< 0.001
Positive emotions
Group I
26.00 (24.00, 31.00)
32.50 (29.25, 35.75)
< 0.001
Group C
24.00 (22.00, 29.00)
24.00 (22.00, 28.00)
0.987
Z
-1.350
-5.218
P value
0.177
< 0.001
Table 4 Negative emotional scores in groups C and I
Project
Before treatment
After treatment
Group I
Group C
Group I
Group C
Upset
2.00 (2.00, 3.00)
3.00 (2.00, 4.00)
2.00 (2.00, 3.00)
3.00 (2.00, 3.00)
P value
0.272
0.023
Hung up
2.00 (2.00, 3.00)
2.00 (2.00, 4.00)
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
P value
0.552
0.231
Guilty
2.00 (2.00, 3.00)
2.00 (2.00, 4.00)
2.00 (1.25, 3.00)
3.00 (2.00, 4.00)
P value
0.890
0.047
Fearful
2.00 (1.25, 3.00)
2.00 (1.00, 3.00)
2.00 (1.00, 2.00)
2.00 (1.00, 2.50)
P value
0.652
0.279
Hostile
2.00 (1.00, 2.00)
2.00 (1.00, 2.00)
1.50 (1.00, 2.00)
2.00 (1.00, 2.00)
P value
0.456
0.782
Irritable
3.00 (2.00, 4.00)
2.00 (2.00, 3.50)
2.00 (2.00, 2.00)
2.00 (2.00, 3.00)
P value
0.372
0.035
Shy
3.00 (2.00, 3.00)
2.00 (2.00, 3.00)
2.00 (1.00, 2.75)
2.00 (1.50, 3.00)
P value
0.402
0.206
Nervous
2.00 (2.00, 4.00)
2.00 (2.00, 4.00)
2.00 (1.00, 3.00)
3.00 (2.00, 4.00)
P value
0.926
0.001
Restless
2.00 (2.00, 3.00)
2.00 (2.00, 3.00)
2.00 (1.00, 3.00)
2.00 (1.50, 3.00)
P value
0.991
0.884
Fearful
2.00 (2.00, 3.00)
2.00 (1.50, 3.00)
2.00 (1.00, 2.00)
2.00 (1.50, 3.00)
P value
0.768
0.019
Negative emotions
25.00 (19.25, 28.00)
22.00 (18.50, 31.50)
20.50 (16.00, 24.00)
24.00 (19.00, 27.50)
P value
0.770
0.028
Table 5 36-Item Short Form Health Survey scores for group C and group I
Project
Before treatment
After treatment
Group I
Group C
Group I
Group C
General health status
30.72 ± 24.91
28.50 ± 20.79
47.63 ± 22.37
34.21 ± 21.80
P value
0.691
0.011
Pahysiology
76.15 ± 13.97
72.43 ± 14.95
81.94 ± 9.65
79.77 ± 13.79
P value
0.279
0.068
Pahysiological functions
25.01 ± 36.83
23.64 ± 33.29
57.40 ± 37.92
33.07 ± 33.86*
P value
0.868
0.005
Body pain
66.38 ± 22.63
62.98 ± 22.18
68.33 ± 19.21
67.57 ± 20.55
P value
0.518
0.868
Emotional function
35.23 ± 41.35
36.94 ± 39.89
62.96 ± 41.23
47.75 ± 38.12
P value
0.854
0.103
Social function
68.04 ± 23.06
60.75 ± 23.90
73.25 ± 20.97
64.88 ± 23.73
P value
0.189
0.115
Energy
51.53 ± 18.16
49.46 ± 24.46
64.18 ± 15.83
50.16 ± 17.41
P value
0.684
0.001
Mental health
67.18 ± 18.57
64.97 ± 16.80
76.11 ± 10.50
66.49 ± 14.98
P value
0.600
0.002
Total score
55.36 ± 15.48
52.66 ± 15.39
67.85 ± 13.02
57.53 ± 13.30
P value
0.460
0.001
Table 6 Analysis of variance for repeated measurements of 36-Item Short Form Health Survey scores in two groups
Project
Time effect
Intergroup effect
Interaction
F
P value
F
P value
F
P value
General health status
16.758
< 0.001
3.613
0.058
2.958
0.065
Pahysiology
9.015
< 0.001
2.678
0.108
0.171
0.814
Pahysiological functions
11.446
< 0.001
4.231
0.041
3.143
0.051
Pahysical pain
3.196
0.045
0.429
0.516
0.168
0.842
Emotional function
8.673
0.001
0.765
0.387
1.512
0.226
Social function
2.770
0.076
4.688
0.032
0.325
0.695
Energy
7.597
0.003
5.329
0.026
4.574
0.019
Mental health
5.235
0.008
5.121
0.028
2.509
0.090
Total score
24.485
< 0.001
5.869
0.021
4.028
0.029
Table 7 Kidney Disease Targets Areas scores for groups C and I
Project
Before treatment
After treatment
Group I
Group C
Group I
Group C
Cognitive
69.79 ± 17.88
69.99 ± 22.27
71.15 ± 16.16
68.15 ± 20.98
P value
0.972
0.496
Symptoms and discomforts
67.36 ± 15.92
65.10 ± 19.43
72.86 ± 13.98
71.28 ± 13.92
P value
0.589
0.631
The burden of kidney disease on life
26.56 ± 22.82
24.66 ± 14.06
36.81 ± 23.94
24.49 ± 24.49
P value
0.671
0.013
Social quality
72.86 ± 16.61
71.70 ± 18.23
77.79 ± 12.56
71.68 ± 14.42
P value
0.781
0.058
The impact of kidney disease on daily life
48.10 ± 15.94
47.65 ± 15.47
56.69 ± 14.21
50.01 ± 17.57
P value
0.902
0.079
Sexuality
17.34 ± 29.75
18.23 ± 34.68
20.83 ± 29.43
18.24 ± 32.09
P value
0.908
0.721
Sleep
56.39 ± 18.08
55.47 ± 14.43
60.97 ± 13.70
58.24 ± 16.92
P value
0.811
0.452
Social support
66.20 ± 16.68
65.76 ± 11.76
73.60 ± 17.55
65.32 ± 12.66
P value
0.898
0.024
Work situation
26.51 ± 27.89
28.37 ± 25.10
33.34 ± 29.29
32.42 ± 24.19
P value
0.763
0.886
Overall health assessment
49.44 ± 18.18
46.49 ± 13.39
59.57 ± 15.00
53.02 ± 11.93
P value
0.430
0.042
Patient satisfaction
56.48 ± 17.52
57.18 ± 19.47
67.57 ± 17.75
54.01 ± 15.48
P value
0.866
0.001
Encouragement from medical staff
78.83 ± 16.05
78.37 ± 19.25
90.97 ± 15.98
78.72 ± 15.54
P value
0.916
0.001
Total score
55.43 ± 10.66
54.42 ± 10.26
61.96 ± 9.35
56.39 ± 8.91
P value
0.675
0.011
Table 8 Analysis of variance for repeated measurements of 36-Item Short Form Health Survey scores in two groups
Project
Time effect
Intergroup effect
Interaction
F
P value
F
P value
F
P value
The burden of kidney disease on life
2.316
0.115
4.237
0.044
2.289
0.116
Cognitive function
0.343
0.686
0.218
0.645
0.502
0.585
Social quality
2.587
0.094
2.587
0.113
2.406
0.109
Symptoms and discomforts
10.124
< 0.001
0.718
0.404
0.246
0.782
The impact of kidney disease on daily life
7.375
0.003
1.993
0.163
2.902
0.068
Sexual function
0.813
0.418
0.025
0.877
0.143
0.807
Sleep
2.587
0.083
0.197
0.658
0.320
0.706
Social support
7.588
0.002
1.558
0.215
9.658
< 0.001
Working conditions
6.746
0.003
0.190
0.664
1.266
0.284
Overall health assessment
3.907
0.021
6.796
0.012
3.655
0.029
Patient satisfaction
2.531
0.083
4.214
0.045
7.403
0.001
Encouragement from medical staff
6.479
0.006
4.563
0.035
6.025
0.007
Total score
14.865
< 0.001
3.995
0.048
3.860
0.029
Citation: Wang DD, Cheng M, Chen CY. Intervention control of aerobic exercise in maintaining quality of life and pulmonary hypertension in hemodialysis patients. World J Clin Cases 2024; 12(20): 4217-4229